T310A mutation decreases TSP50’s ability to interact with NF-κB:IκBα complex and to promote NF-κB signaling. by Yu-Yin Li (323887)

Pharmacokinetic analysis of LY5 in mice and normal dogs. by Peter Y. Yu (4281448)

FEA results meshes for 5N force. by Nathan L. Wright (18389458)

Optimal MUAC cut-off points by gender and age category for screening individuals with underweight, overweight and obesity. by Sheikh Arafat Rahman (21799685)

Viability of SARS-CoV-2 on stainless steel after exposure to simulated sunlight. by Angela Sloan (380916)

The IC50 value of Tan in normal esophageal HET-1A cells. by Dong Yang (141041)

Assessment of exoprotein concentration in a 50-mL culture of MH96. by Marion Schoof (11999106)

The effect of α-MSH treatment on the permeability of cytokine treated Caco-2 monolayers. by Judit Váradi (507449)

Secretion of IL-6 and IL-8 in Caco-2 cells treated with cytokines and α-MSH. by Judit Váradi (507449)

Immunohistochemical staining and analysis of NF-κB activation in cytokine- and α-MSH-treated Caco-2 cells. by Judit Váradi (507449)

The effect of α-MSH treatment on the immunostaining of tight juntion proteins claudin-4 and ZO-1 in cytokine treated Caco-2 cells. by Judit Váradi (507449)

The effect of different concentrations of α-MSH on the electrical resistance of cytokine treated Caco-2 monolayers. by Judit Váradi (507449)

The T37A substitution increases both H5N6 M1 protein stability and H5N6 viral replication in mammals. by Chenxi Wang (284364)

Selection of soil particle sampling points. by Xueting Ma (390540)

C2GnT1 gene knockdown decreases C2-O-sLe^X glycoproteins and C2GnT1 activity. by Catherine A. St. Hill (357388)

“…Note the absence of a detected C2GnT1 protein 50 kDa band. (D) We observed a 30–40% decrease in reactivity with CHO-131 mAb by flow cytometry for LS174T and HepG2 cells that contained C2GnT1 shRNA. …”

Possible Points of Canonical Wnt Inhibition. by Laura Corbett (826084)

“…<p>This study has highlighted six possible points of canonical Wnt inhibition occurring in HSCs. (1) Predominantly non-canonical ligand expression. …”

Differential gene expression assay EC₅₀ values in Huh-7 cells and PHH. by Xuan G. Luong (9761423)

Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Protocol measures. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Cry variables. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”